Skip to content

Medpace

US · MEDP #1015 by market cap Listed 2016
610.54 -23.44 -3.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
4 1
■ Upgrades■ Downgrades
  • 4 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Baird moved from Hold to Buy on 2026-10-23.

Analyst consensus 8 analysts

Buy
Avg price target 691.29 +13.2%
Price target rangecurrent 610.54
Low670.00
Avg691.29
High730.00
Buy 38% Hold 63% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-26 BMO Capital -- Hold 670.00
2026-10-23 TD Cowen -- Hold 673.00
2026-10-23 UBS -- Hold 700.00
2026-10-23 Mizuho Securities -- Buy 730.00
2026-10-23 Baird -- Buy 699.00
2026-10-23 Barclays -- Hold 675.00
2026-10-22 RBC Capital -- Buy 692.00
2026-10-07 Mizuho Securities -- Buy 700.00
2026-10-07 Barclays -- Hold 625.00
2026-10-06 RBC Capital -- Buy 692.00
2026-10-02 UBS -- Hold 673.00
2026-09-30 UBS -- Hold 673.00
2026-09-17 Truist Financial -- Hold --
2026-07-28 Mizuho Securities -- Buy 665.00
2026-07-28 Truist Financial -- Hold 609.00
2026-07-24 Mizuho Securities -- Buy 665.00
2026-07-24 Truist Financial -- Hold 609.00
2026-07-24 Baird -- Hold 624.00
2026-07-23 William Blair -- Hold --
2026-07-23 Truist Financial -- Hold --
2026-07-23 Deutsche Bank -- Hold 535.00
2026-07-23 BMO Capital -- Hold 600.00
2026-07-23 Leerink Partners -- Hold 620.00
2026-07-23 RBC Capital -- Buy 692.00
2026-07-22 William Blair -- Hold --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-23 Baird Hold → Buy 699.00
2026-10-23 TD Cowen Sell → Hold 673.00
2026-07-08 Baird Buy → Hold 547.00
2026-03-06 Barclays Sell → Hold 500.00
2026-02-10 Baird Hold → Buy 564.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-21 After close ±13.79% -1.29% (in line)
2026/Q2 2026-07-22 After close ±15.30% +14.71% (in line)
2026/Q1 2026-04-22 After close ±14.69% -22.63% (beat)
2025/Q4 2026-02-09 After close ±11.56% -15.90% (beat)
2025/Q3 2025-10-22 After close ±13.98% +9.12% (in line)
2025/Q2 2025-07-21 After close ±13.70% +54.67% (beat)
2025/Q1 2025-04-21 After close ±15.75% -2.32% (in line)
2024/Q4 2025-02-10 After close ±11.60% -7.52% (in line)
2024/Q3 2024-10-21 After close ±15.79% -7.47% (in line)
2024/Q2 2024-07-22 After close ±13.00% -18.27% (beat)
2024/Q1 2024-04-22 After close ±13.36% +8.21% (in line)
2023/Q4 2024-02-12 After close ±12.20% +12.30% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Medpace discussion 0 comments

Add a comment